Expressing support for the designation of September 2022 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

Bill 117 H.Res. 1330 is a resolution that aims to designate September 2022 as "Sickle Cell Disease Awareness Month" in the United States. The purpose of this designation is to raise awareness about sickle cell disease and educate communities about the importance of research, early detection methods, effective treatments, and preventative care programs for individuals affected by the disease.

Sickle cell disease is a genetic blood disorder that affects red blood cells, causing them to become rigid and sickle-shaped. This can lead to various complications, including pain crises, organ damage, and an increased risk of infections. It primarily affects African Americans, but can also impact individuals of Hispanic, Mediterranean, and Middle Eastern descent.

The resolution emphasizes the need for increased awareness and education about sickle cell disease in order to improve outcomes for those living with the condition. It also highlights the importance of research to develop new treatments and preventative care programs to address the complications associated with the disease. By designating September 2022 as "Sickle Cell Disease Awareness Month," the resolution aims to bring attention to this often overlooked health issue and encourage communities to take action to support individuals affected by sickle cell disease. It is a step towards promoting greater understanding and advocacy for those living with this chronic condition.